Literature DB >> 31063810

The incidence and clinical outcome of complications in 4,000 consecutive strabismus operations.

Ailsa E Ritchie1, Nadeem Ali2.   

Abstract

PURPOSE: To test the validity of the British Ophthalmic Surveillance Unit (BOSU) study's incidence figure of severe complications following strabismus surgery and to determine the incidence, type, risk factors, and outcome of all strabismus surgery complications at a single institution.
METHODS: A prospective audit of consecutive strabismus operations performed by consultants or trainees was carried out between 2011 and 2016 at Moorfields Eye Hospital NHS Foundation Trust. Patient diagnosis, age, sex, surgical details, complications, and outcome were recorded from hospital records. We classified complications as minor, moderate, or severe. The outcome was graded using the Bradbury and Taylor grading system (I to IV), with a poor or very poor outcome meaning loss of corrected visual acuity or unexpected primary position diplopia.
RESULTS: A total of 4,076 consecutive strabismus operations were performed during the study period. There were 46 (1.13%) complications, of which 28 (0.69%) were minor, 7 (0.17%) were moderate, and 9 (0.22%) were severe. Only 1 patient (0.02%) had a poor visual outcome. Two patients had nonocular postoperative complications (0.05%).
CONCLUSIONS: In this large, prospective series, we found the rate of severe complications of strabismus surgery to be 1 in 455 cases. Our results validate the findings of the BOSU study. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31063810     DOI: 10.1016/j.jaapos.2018.08.015

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  1 in total

1.  Incidence of infectious complications following strabismus surgery.

Authors:  Hwan Heo; Won Yeol Ryu; Arthika Chandramohan; Scott R Lambert
Journal:  J AAPOS       Date:  2022-04-15       Impact factor: 1.325

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.